ID   IL13_HUMAN              Reviewed;         146 AA.
AC   P35225; O43644; Q4VB52; Q9UDC7;
DT   01-FEB-1994, integrated into UniProtKB/Swiss-Prot.
DT   24-JAN-2024, sequence version 3.
DT   28-JAN-2026, entry version 230.
DE   RecName: Full=Interleukin-13;
DE            Short=IL-13;
DE   Flags: Precursor;
GN   Name=IL13; Synonyms=NC30;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND FUNCTION.
RX   PubMed=8096327; DOI=10.1038/362248a0;
RA   Minty A.J., Chalon P., Derocq J.-M., Dumont X., Guillemot J.-C., Kaghad M.,
RA   Labit C., Leplatois P., Liauzun P., Miloux B., Minty C., Casellas P.,
RA   Loison G., Lupker J., Shire D., Ferrara P., Caput D.;
RT   "Interleukin-13 is a new human lymphokine regulating inflammatory and
RT   immune responses.";
RL   Nature 362:248-250(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8097324; DOI=10.1073/pnas.90.8.3735;
RA   McKenzie A.N., Culpepper J.A., Waal Malefyt R., Briere F., Punnonen J.,
RA   Aversa G., Sato A., Dang W., Cocks B.G., Menon S., de Vries J.E.,
RA   Banchereau J., Zurawski G.R.;
RT   "Interleukin 13, a T-cell-derived cytokine that regulates human monocyte
RT   and B-cell function.";
RL   Proc. Natl. Acad. Sci. U.S.A. 90:3735-3739(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Blood;
RX   PubMed=7721105; DOI=10.1016/0378-1119(94)00720-d;
RA   Smirnov D.V., Smirnova M.G., Korobko V.G., Frolova E.I.;
RT   "Tandem arrangement of human genes for interleukin-4 and interleukin-13:
RT   resemblance in their organization.";
RL   Gene 155:277-281(1995).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=8605348;
RA   Dolganov G., Bort S., Lovett M., Burr J., Schubert L., Short D., McGurn M.,
RA   Gibson C., Lewis D.B.;
RT   "Coexpression of the interleukin-13 and interleukin-4 genes correlates with
RT   their physical linkage in the cytokine gene cluster on human chromosome
RT   5q23-31.";
RL   Blood 87:3316-3326(1996).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   SeattleSNPs variation discovery resource;
RL   Submitted (JUN-2001) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Grigoriev I., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Israni S., Jett J., Kadner K., Kimball H., Kobayashi A.,
RA   Lopez F., Lou Y., Martinez D., Medina C., Morgan J., Nandkeshwar R.,
RA   Noonan J.P., Pitluck S., Pollard M., Predki P., Priest J., Ramirez L.,
RA   Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A., Thayer N.,
RA   Tice H., Tsai M., Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J.,
RA   Dickson M., Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A.,
RA   Rokhsar D.S., Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 14-146.
RA   Jang J.S., Kim B.E.;
RL   Submitted (JAN-1998) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 15-63.
RC   TISSUE=Peripheral blood lymphocyte;
RX   PubMed=1408833; DOI=10.1093/nar/20.19.5173;
RA   Morgan J.G., Dolganov G.M., Robbins S.E., Hinton L.M., Lovett M.;
RT   "The selective isolation of novel cDNAs encoded by the regions surrounding
RT   the human interleukin 4 and 5 genes.";
RL   Nucleic Acids Res. 20:5173-5179(1992).
RN   [10]
RP   FUNCTION.
RX   PubMed=7903680; DOI=10.1084/jem.179.1.135;
RA   Defrance T., Carayon P., Billian G., Guillemot J.C., Minty A., Caput D.,
RA   Ferrara P.;
RT   "Interleukin 13 is a B cell stimulating factor.";
RL   J. Exp. Med. 179:135-143(1994).
RN   [11]
RP   FUNCTION.
RX   PubMed=8759755;
RA   Luttmann W., Knoechel B., Foerster M., Matthys H., Virchow J.C. Jr.,
RA   Kroegel C.;
RT   "Activation of human eosinophils by IL-13. Induction of CD69 surface
RT   antigen, its relationship to messenger RNA expression, and promotion of
RT   cellular viability.";
RL   J. Immunol. 157:1678-1683(1996).
RN   [12]
RP   FUNCTION.
RX   PubMed=9013879; DOI=10.1016/s0014-5793(96)01462-7;
RA   Miloux B., Laurent P., Bonnin O., Lupker J., Caput D., Vita N., Ferrara P.;
RT   "Cloning of the human IL-13R alpha1 chain and reconstitution with the IL4R
RT   alpha of a functional IL-4/IL-13 receptor complex.";
RL   FEBS Lett. 401:163-166(1997).
RN   [13]
RP   FUNCTION.
RX   PubMed=8639787;
RA   Schnyder B., Lugli S., Feng N., Etter H., Lutz R.A., Ryffel B.,
RA   Sugamura K., Wunderli-Allenspach H., Moser R.;
RT   "Interleukin-4 (IL-4) and IL-13 bind to a shared heterodimeric complex on
RT   endothelial cells mediating vascular cell adhesion molecule-1 induction in
RT   the absence of the common gamma chain.";
RL   Blood 87:4286-4295(1996).
RN   [14]
RP   FUNCTION.
RX   PubMed=21622864; DOI=10.4049/jimmunol.1100467;
RA   Kasaian M.T., Raible D., Marquette K., Cook T.A., Zhou S., Tan X.Y.,
RA   Tchistiakova L.;
RT   "IL-13 antibodies influence IL-13 clearance in humans by modulating
RT   scavenger activity of IL-13Ralpha2.";
RL   J. Immunol. 187:561-569(2011).
RN   [15]
RP   STRUCTURE BY NMR OF 35-146, AND DISULFIDE BONDS.
RX   PubMed=11419948; DOI=10.1006/jmbi.2001.4764;
RA   Moy F.J., Diblasio E., Wilhelm J., Powers R.;
RT   "Solution structure of human IL-13 and implication for receptor binding.";
RL   J. Mol. Biol. 310:219-230(2001).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (3.05 ANGSTROMS) OF 15-146 IN COMPLEX WITH IL13RA2,
RP   AND DISULFIDE BONDS.
RX   PubMed=20223216; DOI=10.1016/j.str.2010.01.003;
RA   Lupardus P.J., Birnbaum M.E., Garcia K.C.;
RT   "Molecular basis for shared cytokine recognition revealed in the structure
RT   of an unusually high affinity complex between IL-13 and IL-13Ralpha2.";
RL   Structure 18:332-342(2010).
RN   [17]
RP   INVOLVEMENT IN ALRH, AND VARIANT ARG-144.
RX   PubMed=10699178; DOI=10.1093/hmg/9.4.549;
RA   Heinzmann A., Mao X.-Q., Akaiwa M., Kreomer R.T., Gao P.-S., Ohshima K.,
RA   Umeshita R., Abe Y., Braun S., Yamashita T., Roberts M.H., Sugimoto R.,
RA   Arima K., Arinobu Y., Yu B., Kruse S., Enomoto T., Dake Y., Kawai M.,
RA   Shimazu S., Sasaki S., Adra C.N., Kitaichi M., Inoue H., Yamauchi K.,
RA   Tomichi N., Kurimoto F., Hamasaki N., Hopkin J.M., Izuhara K.,
RA   Shirakawa T., Deichmann K.A.;
RT   "Genetic variants of IL-13 signalling and human asthma and atopy.";
RL   Hum. Mol. Genet. 9:549-559(2000).
RN   [18]
RP   INVOLVEMENT IN ALRH, AND VARIANT ARG-144.
RX   PubMed=11588017; DOI=10.1165/ajrcmb.25.3.4483;
RA   Howard T.D., Whittaker P.A., Zaiman A.L., Koppelman G.H., Xu J.,
RA   Hanley M.T., Meyers D.A., Postma D.S., Bleecker E.R.;
RT   "Identification and association of polymorphisms in the interleukin-13 gene
RT   with asthma and atopy in a Dutch population.";
RL   Am. J. Respir. Cell Mol. Biol. 25:377-384(2001).
RN   [19]
RP   INVOLVEMENT IN ALRH, AND VARIANT ARG-144.
RX   PubMed=12928861; DOI=10.1007/s00439-003-1001-x;
RA   Wang M., Xing Z.-M., Lu C., Ma Y.-X., Yu D.-L., Yan Z., Wang S.-W.,
RA   Yu L.-S.;
RT   "A common IL-13 Arg130Gln single nucleotide polymorphism among Chinese
RT   atopy patients with allergic rhinitis.";
RL   Hum. Genet. 113:387-390(2003).
CC   -!- FUNCTION: Cytokine that plays important roles in allergic inflammation
CC       and immune response to parasite infection (PubMed:8096327,
CC       PubMed:8097324). Synergizes with IL2 in regulating interferon-gamma
CC       synthesis (PubMed:8096327). Stimulates B-cell proliferation, and
CC       activation of eosinophils, basophils, and mast cells (PubMed:7903680,
CC       PubMed:8759755). Plays an important role in controlling IL33 activity
CC       by modulating the production of transmembrane and soluble forms of
CC       interleukin-1 receptor-like 1/IL1RL1 (By similarity). Displays the
CC       capacity to antagonize Th1-driven proinflammatory immune response and
CC       downregulates synthesis of many proinflammatory cytokines including
CC       IL1, IL6, IL10, IL12 and TNF through a mechanism that partially
CC       involves suppression of NF-kappa-B (By similarity). Also functions on
CC       nonhematopoietic cells, including endothelial cells where it induces
CC       vascular cell adhesion protein 1/VCAM1, which is important in the
CC       recruitment of eosinophils (PubMed:8639787). Exerts its biological
CC       effects through its receptors which comprises the IL4R chain and the
CC       IL13RA1 chain, to activate JAK1 and TYK2, leading to the activation of
CC       STAT6 (PubMed:9013879). Aside from IL13RA1, another receptor IL13RA2
CC       acts as a high affinity decoy for IL13 and mediates internalization and
CC       depletion of extracellular IL13 (PubMed:21622864).
CC       {ECO:0000250|UniProtKB:P20109, ECO:0000250|UniProtKB:P42203,
CC       ECO:0000269|PubMed:21622864, ECO:0000269|PubMed:7903680,
CC       ECO:0000269|PubMed:8096327, ECO:0000269|PubMed:8097324,
CC       ECO:0000269|PubMed:8639787, ECO:0000269|PubMed:8759755,
CC       ECO:0000269|PubMed:9013879}.
CC   -!- SUBUNIT: Interacts with IL13RA2. {ECO:0000269|PubMed:20223216}.
CC   -!- INTERACTION:
CC       P35225; P78552: IL13RA1; NbExp=7; IntAct=EBI-1647828, EBI-1391535;
CC       P35225; Q14627: IL13RA2; NbExp=9; IntAct=EBI-1647828, EBI-4320063;
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- DISEASE: Allergic rhinitis (ALRH) [MIM:607154]: A common disease with
CC       complex inheritance characterized by mucosal inflammation caused by
CC       allergen exposure. {ECO:0000269|PubMed:10699178,
CC       ECO:0000269|PubMed:11588017, ECO:0000269|PubMed:12928861}. Note=Disease
CC       susceptibility may be associated with variants affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the IL-4/IL-13 family. {ECO:0000305}.
CC   -!- CAUTION: It is uncertain whether Met-1 or Met-15 is the initiator.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA36107.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAA83738.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAB01681.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAC03535.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAK53823.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=CAA48824.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Interleukin-13 entry;
CC       URL="https://en.wikipedia.org/wiki/Interleukin_13";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X69079; CAA48823.1; -; mRNA.
DR   EMBL; X69079; CAA48824.1; ALT_INIT; mRNA.
DR   EMBL; L06801; AAA36107.1; ALT_INIT; mRNA.
DR   EMBL; U10307; AAA83738.1; ALT_INIT; Genomic_DNA.
DR   EMBL; U31120; AAB01681.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AF377331; AAK53823.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AC004039; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC096139; AAH96139.1; -; mRNA.
DR   EMBL; AF043334; AAC03535.1; ALT_INIT; mRNA.
DR   CCDS; CCDS4157.1; -.
DR   PIR; I38060; A47481.
DR   RefSeq; NP_002179.2; NM_002188.2.
DR   PDB; 1GA3; NMR; -; A=35-146.
DR   PDB; 1IJZ; NMR; -; A=35-146.
DR   PDB; 1IK0; NMR; -; A=35-146.
DR   PDB; 3BPO; X-ray; 3.00 A; A=34-146.
DR   PDB; 3G6D; X-ray; 3.20 A; A=35-146.
DR   PDB; 3L5W; X-ray; 2.00 A; I/J=35-146.
DR   PDB; 3L5X; X-ray; 1.90 A; A=35-146.
DR   PDB; 3LB6; X-ray; 3.05 A; A/B=15-146.
DR   PDB; 4I77; X-ray; 1.90 A; Z=35-146.
DR   PDB; 4PS4; X-ray; 2.80 A; A=35-146.
DR   PDB; 5E4E; X-ray; 3.00 A; A=34-146.
DR   PDB; 5L6Y; X-ray; 1.99 A; C=35-146.
DR   PDB; 8BLQ; EM; 3.97 A; D=38-146.
DR   PDBsum; 1GA3; -.
DR   PDBsum; 1IJZ; -.
DR   PDBsum; 1IK0; -.
DR   PDBsum; 3BPO; -.
DR   PDBsum; 3G6D; -.
DR   PDBsum; 3L5W; -.
DR   PDBsum; 3L5X; -.
DR   PDBsum; 3LB6; -.
DR   PDBsum; 4I77; -.
DR   PDBsum; 4PS4; -.
DR   PDBsum; 5E4E; -.
DR   PDBsum; 5L6Y; -.
DR   PDBsum; 8BLQ; -.
DR   AlphaFoldDB; P35225; -.
DR   BMRB; P35225; -.
DR   SMR; P35225; -.
DR   BioGRID; 109810; 17.
DR   ComplexPortal; CPX-844; Interleukin-13 receptor-ligand alpha 1 complex.
DR   ComplexPortal; CPX-847; TMEM219-Interleukin-13 decoy-receptor-ligand alpha 2 complex.
DR   ComplexPortal; CPX-9184; Chitinase 3-like-1-tmem219-interleukin-13 receptor-ligand alpha-2 signalling complex.
DR   CORUM; P35225; -.
DR   DIP; DIP-3224N; -.
DR   FunCoup; P35225; 651.
DR   IntAct; P35225; 17.
DR   MINT; P35225; -.
DR   STRING; 9606.ENSP00000304915; -.
DR   BindingDB; P35225; -.
DR   ChEMBL; CHEMBL3580486; -.
DR   DrugBank; DB05305; Cintredekin besudotox.
DR   DrugBank; DB15130; Dexpramipexole.
DR   DrugBank; DB12159; Dupilumab.
DR   DrugBank; DB11914; Lebrikizumab.
DR   DrugBank; DB16318; Romilkimab.
DR   DrugBank; DB12169; Tralokinumab.
DR   DrugCentral; P35225; -.
DR   GlyCosmos; P35225; 4 sites, No reported glycans.
DR   GlyGen; P35225; 4 sites.
DR   BioMuta; IL13; -.
DR   DMDM; 239938644; -.
DR   MassIVE; P35225; -.
DR   PaxDb; 9606-ENSP00000304915; -.
DR   PeptideAtlas; P35225; -.
DR   ABCD; P35225; 616 sequenced antibodies.
DR   Antibodypedia; 14499; 1437 antibodies from 45 providers.
DR   DNASU; 3596; -.
DR   Ensembl; ENST00000304506.7; ENSP00000304915.3; ENSG00000169194.10.
DR   GeneID; 3596; -.
DR   KEGG; hsa:3596; -.
DR   MANE-Select; ENST00000304506.7; ENSP00000304915.3; NM_002188.3; NP_002179.2.
DR   UCSC; uc003kxj.2; human.
DR   AGR; HGNC:5973; -.
DR   ClinPGx; PA199; -.
DR   CTD; 3596; -.
DR   DisGeNET; 3596; -.
DR   GeneCards; IL13; -.
DR   HGNC; HGNC:5973; IL13.
DR   HPA; ENSG00000169194; Tissue enriched (testis).
DR   MalaCards; IL13; -.
DR   MIM; 147683; gene.
DR   MIM; 607154; phenotype.
DR   OpenTargets; ENSG00000169194; -.
DR   VEuPathDB; HostDB:ENSG00000169194; -.
DR   eggNOG; ENOG502SZKX; Eukaryota.
DR   GeneTree; ENSGT00390000003225; -.
DR   InParanoid; P35225; -.
DR   OMA; KTPLCNG; -.
DR   OrthoDB; 9447464at2759; -.
DR   PAN-GO; P35225; 2 GO annotations based on evolutionary models.
DR   PhylomeDB; P35225; -.
DR   PathwayCommons; P35225; -.
DR   Reactome; R-HSA-6785807; Interleukin-4 and Interleukin-13 signaling.
DR   Reactome; R-HSA-9012546; Interleukin-18 signaling.
DR   SignaLink; P35225; -.
DR   SIGNOR; P35225; -.
DR   Agora; ENSG00000169194; -.
DR   BioGRID-ORCS; 3596; 7 hits in 1144 CRISPR screens.
DR   ChiTaRS; IL13; human.
DR   EvolutionaryTrace; P35225; -.
DR   GeneWiki; Interleukin_13; -.
DR   GenomeRNAi; 3596; -.
DR   Pharos; P35225; Tclin.
DR   PRO; PR:P35225; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   RNAct; P35225; protein.
DR   Bgee; ENSG00000169194; Expressed in left testis and 115 other cell types or tissues.
DR   ExpressionAtlas; P35225; baseline and differential.
DR   GO; GO:0005737; C:cytoplasm; IEA:Ensembl.
DR   GO; GO:0009897; C:external side of plasma membrane; IEA:Ensembl.
DR   GO; GO:0005576; C:extracellular region; IDA:BHF-UCL.
DR   GO; GO:0005615; C:extracellular space; ISS:UniProtKB.
DR   GO; GO:0005125; F:cytokine activity; IDA:UniProt.
DR   GO; GO:0005144; F:interleukin-13 receptor binding; IBA:GO_Central.
DR   GO; GO:0071260; P:cellular response to mechanical stimulus; IEA:Ensembl.
DR   GO; GO:0006955; P:immune response; IEA:InterPro.
DR   GO; GO:0006954; P:inflammatory response; IBA:GO_Central.
DR   GO; GO:0035772; P:interleukin-13-mediated signaling pathway; IDA:ARUK-UCL.
DR   GO; GO:0042116; P:macrophage activation; IGI:ARUK-UCL.
DR   GO; GO:0001774; P:microglial cell activation; IEA:Ensembl.
DR   GO; GO:1903660; P:negative regulation of complement-dependent cytotoxicity; IMP:AgBase.
DR   GO; GO:2000352; P:negative regulation of endothelial cell apoptotic process; IMP:AgBase.
DR   GO; GO:0050728; P:negative regulation of inflammatory response; IGI:ARUK-UCL.
DR   GO; GO:1901247; P:negative regulation of lung ciliated cell differentiation; NAS:BHF-UCL.
DR   GO; GO:0071635; P:negative regulation of transforming growth factor beta production; IEA:Ensembl.
DR   GO; GO:0030890; P:positive regulation of B cell proliferation; IEA:Ensembl.
DR   GO; GO:0120162; P:positive regulation of cold-induced thermogenesis; ISS:YuBioLab.
DR   GO; GO:0010628; P:positive regulation of gene expression; ISS:ARUK-UCL.
DR   GO; GO:0002639; P:positive regulation of immunoglobulin production; IBA:GO_Central.
DR   GO; GO:0032733; P:positive regulation of interleukin-10 production; IGI:ARUK-UCL.
DR   GO; GO:1901251; P:positive regulation of lung goblet cell differentiation; NAS:BHF-UCL.
DR   GO; GO:0043032; P:positive regulation of macrophage activation; IEA:Ensembl.
DR   GO; GO:0043306; P:positive regulation of mast cell degranulation; IEA:Ensembl.
DR   GO; GO:2000231; P:positive regulation of pancreatic stellate cell proliferation; IEA:Ensembl.
DR   GO; GO:0050714; P:positive regulation of protein secretion; IEA:Ensembl.
DR   GO; GO:0051281; P:positive regulation of release of sequestered calcium ion into cytosol; IEA:Ensembl.
DR   GO; GO:0048661; P:positive regulation of smooth muscle cell proliferation; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IGI:ARUK-UCL.
DR   GO; GO:0010155; P:regulation of proton transport; IEA:Ensembl.
DR   GO; GO:0045471; P:response to ethanol; IEA:Ensembl.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl.
DR   GO; GO:0009624; P:response to nematode; IEA:Ensembl.
DR   GO; GO:0035094; P:response to nicotine; IEA:Ensembl.
DR   GO; GO:0010269; P:response to selenium ion; IEA:Ensembl.
DR   FunFam; 1.20.1250.10:FF:000029; Interleukin-13; 1.
DR   Gene3D; 1.20.1250.10; -; 1.
DR   InterPro; IPR009079; 4_helix_cytokine-like_core.
DR   InterPro; IPR020470; IL-13.
DR   InterPro; IPR001325; IL-4/IL-13.
DR   InterPro; IPR018096; IL-4/IL-13_CS.
DR   PANTHER; PTHR48486; INTERLEUKIN-13; 1.
DR   PANTHER; PTHR48486:SF1; INTERLEUKIN-13; 1.
DR   Pfam; PF03487; IL13; 1.
DR   PRINTS; PR01929; INTRLEUKIN13.
DR   SMART; SM00190; IL4_13; 1.
DR   SUPFAM; SSF47266; 4-helical cytokines; 1.
DR   PROSITE; PS00838; INTERLEUKIN_4_13; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cytokine; Disulfide bond; Glycoprotein;
KW   Proteomics identification; Reference proteome; Secreted; Signal.
FT   SIGNAL          1..24
FT                   /evidence="ECO:0000255"
FT   CHAIN           25..146
FT                   /note="Interleukin-13"
FT                   /id="PRO_0000015547"
FT   CARBOHYD        52
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        63
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        71
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        86
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        62..90
FT                   /evidence="ECO:0000269|PubMed:11419948,
FT                   ECO:0000269|PubMed:20223216"
FT   DISULFID        78..104
FT                   /evidence="ECO:0000269|PubMed:11419948,
FT                   ECO:0000269|PubMed:20223216"
FT   VARIANT         144
FT                   /note="Q -> R (probable protective factor against ALRH; may
FT                   be associated with decreased risk for asthma development;
FT                   at homozygosity may be associated with lower levels of
FT                   serum total IgE in some allergic rhinitis patients;
FT                   dbSNP:rs20541)"
FT                   /evidence="ECO:0000269|PubMed:10699178,
FT                   ECO:0000269|PubMed:11588017, ECO:0000269|PubMed:12928861"
FT                   /id="VAR_010037"
FT   CONFLICT        1
FT                   /note="M -> R (in Ref. 2; CAA48824)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        26
FT                   /note="T -> A (in Ref. 9; no nucleotide entry)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        32
FT                   /note="A -> D (in Ref. 9; no nucleotide entry)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        51
FT                   /note="V -> S (in Ref. 9; no nucleotide entry)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        56
FT                   /note="N -> T (in Ref. 9; no nucleotide entry)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        59
FT                   /note="A -> R (in Ref. 3; AAA83738)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        101
FT                   /note="S -> G (in Ref. 8; AAC03535)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        112
FT                   /note="Missing (in Ref. 3; AAA83738)"
FT                   /evidence="ECO:0000305"
FT   HELIX           41..54
FT                   /evidence="ECO:0007829|PDB:3L5X"
FT   TURN            61..64
FT                   /evidence="ECO:0007829|PDB:3L5X"
FT   STRAND          66..68
FT                   /evidence="ECO:0007829|PDB:3L5X"
FT   TURN            74..76
FT                   /evidence="ECO:0007829|PDB:3L5X"
FT   HELIX           77..84
FT                   /evidence="ECO:0007829|PDB:3L5X"
FT   HELIX           91..93
FT                   /evidence="ECO:0007829|PDB:3L5X"
FT   HELIX           94..103
FT                   /evidence="ECO:0007829|PDB:3L5X"
FT   STRAND          104..106
FT                   /evidence="ECO:0007829|PDB:3LB6"
FT   HELIX           113..116
FT                   /evidence="ECO:0007829|PDB:5E4E"
FT   STRAND          122..124
FT                   /evidence="ECO:0007829|PDB:3L5X"
FT   HELIX           125..142
FT                   /evidence="ECO:0007829|PDB:3L5X"
SQ   SEQUENCE   146 AA;  15788 MW;  BE2D441CF913D129 CRC64;
     MHPLLNPLLL ALGLMALLLT TVIALTCLGG FASPGPVPPS TALRELIEEL VNITQNQKAP
     LCNGSMVWSI NLTAGMYCAA LESLINVSGC SAIEKTQRML SGFCPHKVSA GQFSSLHVRD
     TKIEVAQFVK DLLLHLKKLF REGQFN
//
